Goal posts haven’t been changed or moved, I’m arguing timelines are actually sooner to transaction.
Proving out multiple indications on FTO would see us here at 2030.
This AML/Breast cancer path could see partnerships now or within the next 6 months, and could see a transaction of some kind within 2.5yrs.
If all you’re doing is looking at when final P2 results on a graph are estimated in 2028 then you need to re-read and understand the trials, inflection points, and near term catalysts.
Cause guess what P3 & approvals might be 2030+ if it’s needed. We just either won’t be around then in current form and all going well you can guarantee the SP will be better reflected by 2025/2026 on clinical readouts.
RAC had a plan before, now they have a strategy. Big difference.
One is good for the back of an envelope, the other is good for presentation and buy in from investors, big pharma, and clinicians.
- Forums
- ASX - By Stock
- RAC
- Ann: Race Strategic Update August 2023
Ann: Race Strategic Update August 2023, page-113
-
- There are more pages in this discussion • 480 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.52 |
Change
-0.030(1.94%) |
Mkt cap ! $258.9M |
Open | High | Low | Value | Volume |
$1.57 | $1.57 | $1.50 | $75.34K | 49.79K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 300 | $1.51 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.52 | 49256 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 300 | 1.510 |
1 | 996 | 1.505 |
5 | 17423 | 1.500 |
1 | 13043 | 1.495 |
1 | 6000 | 1.490 |
Price($) | Vol. | No. |
---|---|---|
1.520 | 49256 | 1 |
1.580 | 6715 | 2 |
1.595 | 12136 | 1 |
1.600 | 8509 | 3 |
1.620 | 6328 | 2 |
Last trade - 16.10pm 19/08/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |